CPBIO Holding Company Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments: Biotech Business and Investment Business. The Biochemical segment is engaged in the manufacture and/or sale of animal health products and chlortetracycline, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance efficiency under the Shihao and Citifac brand names. The company offers products such as gut & health enhancement, antibioticsanticoc & antiparasitics, bioprotection, detection kits, enzyme, plant extracts, vaccine, and trade. The company also provides solution for poultry, swine, ruminants, and aquaculture. The Investment segment is engaged in the trading of machinery and the manufacture and sale of automotive parts; and caterpillar products, including excavators, power generators, bulldozers and compactors, as well as spare parts; and the manufacture and sale of motorcycle carburetors. The company serves livestock farms, pharmaceutical companies, trading companies, feed mills, automobile manufacturers, and motorcycle manufacturers. CPBIO Holding Company Limited was formerly known as Chia Tai Enterprises International Limited and changed its name to CPBIO Holding Company Limited in July 2026. CPBIO Holding Company Limited was incorporated in 1987 and is based in Central, Hong Kong.
Research context
Chia Tai Enterprises International Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Chia Tai Enterprises International Limited is currently in a long term uptrend where the price is trading 11.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Chia Tai Enterprises International Limited's total revenue rose by 214.8% to $94M since the same quarter in the previous year.
Its net income has increased by 575.3% to $16M since the same quarter in the previous year.
Finally, its free cash flow grew by 122.3% to $6M since the same quarter in the previous year.
Based on the above factors, Chia Tai Enterprises International Limited gets an overall score of 5/5.